ZAP70 and B-cell chronic lymphocytic leukemia: On the other hand, allo-SCT in patients with CLL has been demonstrated to avoid the adverse effects of deletion 17p, unmutated immunoglobulin heavy-chain variable region gene (IGHV), and Zeta-chain-associated protein kinase 70 (ZAP-70) among others (24, 27-30).